Efectos adversos asociados al uso de anabolizantes en deportistas: revisión sistemática.
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 45, doi. 10.30827/ars.v59i1.7278
- By:
- Publication type:
- Article
Works matching IS 00042927 AND DT 2018 AND VI 59 AND IP 1
Results: 6
1
2
Revisión de dosieres de heparina y enoxaparina: Incumplimiento de la normativa de Costa Rica para el registro sanitario de biosimilares farmacéuticos.
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 27, doi. 10.30827/ars.v59i1.7277
- By:
- Publication type:
- Article
3
Pharmacology of Natural Products: An recent approach on Calotropis gigantea and Calotropis procera.
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 37, doi. 10.30827/ars.v59i1.7276
- By:
- Publication type:
- Article
4
Barriers for implementation of cosmetovigilance in Peru: Structural Equation Modeling Using Partial Least Square.
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 21, doi. 10.30827/ars.v59i1.7275
- By:
- Publication type:
- Article
5
Development and characterization of a novel nano-liposomal formulation of Alendronate Sodium loaded with biodegradable polymer.
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 9, doi. 10.30827/ars.v59i1.7274
- By:
- Publication type:
- Article
6
Declaración de Sant Joan d'Alacant en defensa del Acceso Abierto a las publicaciones científicas, del grupo de editores de revistas españolas sobre ciencias de la salud (GERECS).
- Published in:
- Ars Pharmaceutica, 2018, v. 59, n. 1, p. 5
- Publication type:
- Article